The pathogenesis of the disorders of calcium metabolism is not fully understood. This review discusses the studies in which metabolomics was applied in this area. Indeed, metabolomics could play an essential role in discovering biomarkers and elucidating pathological mechanisms. Despite the limited bibliography, the present review highlights the potential of metabolomics in identifying the biomarkers of some of the most common endocrine disorders, such as primary hyperparathyroidism (PHPT), secondary hyperparathyroidism (SHPT), calcium deficiency, osteoporosis and vitamin D supplementation. Metabolites related to above-mentioned diseorders were grouped into specific classes and mapped into metabolic pathways. Furthermore, disturbed metabolic pathways can open up new directions for the in-depth exploration of the basic mechanisms of these diseases at the molecular level.
CITATION STYLE
Podgórska, B., Wielogórska-Partyka, M., Godzień, J., Siemińska, J., Ciborowski, M., Szelachowska, M., … Siewko, K. (2022, September 1). Applications of Metabolomics in Calcium Metabolism Disorders in Humans. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms231810407
Mendeley helps you to discover research relevant for your work.